No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mL
| Autor: | Shyam Kottilil, Ruth M. Pfeiffer, M.P.H. Jordan J. Feld M.D., M.P.H. Thomas R. O'Brien M.D. |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
0301 basic medicine
Ledipasvir Hepatology Sofosbuvir biology business.industry Hepacivirus biology.organism_classification Virology 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine chemistry Hepatitis C virus RNA Hcv treatment medicine LEDIPASVIR/SOFOSBUVIR 030211 gastroenterology & hepatology business medicine.drug |
| Zdroj: | Hepatology. 63:28-30 |
| ISSN: | 1527-3350 0270-9139 |
| DOI: | 10.1002/hep.28292 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text